Cytek BioSciences could be valued at more than $2.3 billion as IPO terms have been set

Retrieved on: 2021-07-19 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Cytek BioSciences could be valued at more than $2.3 billion as IPO terms have been set. View article details on hiswai:

Excerpt

Morgan Stanley, Goldman Sachs, Piper Sandler and Cowen are the underwriters. The company recorded net income of $13.7 million on revenue of ...

Article found on: www.marketwatch.com